4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-056779
Co-Chief Executive Officer gave up 588 shares (to pay taxes)
- Co-Chief Executive Officer acquired 1,563 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WEST MICHAEL D Co-Chief Executive Officer | 2017-10-10 | Option exercise | +1,563 | 884,427 | D | ||
| WEST MICHAEL D Co-Chief Executive Officer | 2017-10-10 | Shares withheld for taxes | −588 | $2.81 | $1,652 | 883,839 | D |
| Derivatives | |||||||
| WEST MICHAEL D Co-Chief Executive Officer | 2017-10-10 | Option exercise · Restricted Stock Units | −1,563 | 15,625 | D | ||
Loading xslF345X03/doc4.xml…